Effect of a Kampo preparation, byakkokaninjinto, on pharmacokinetics of ciprofloxacin and tetracycline

Biological and Pharmaceutical Bulletin

Volumn 32, Issue 6, 2009, Pages 1080-1084

  Ohnishi, Masafumi ^a   Hitoshi, Kotaro ^b   Katoh, Miki ^b   Nadai, Masayuki ^b   Abe, Fumie ^a   Kurono, Shunsuke ^a   Saito, Hiroko ^a   Haniuda, Masayuki ^a   Hasegawa, Takaaki ^a  

^a AICHI MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b MEIJO UNIVERSITY   (Japan)

Author keywords

Bioavailability; Byakkokaninjinto; Ciprofloxacin; Drug interaction; Kampo preparation; Tetracycline

Indexed keywords

ANTIINFLAMMATORY AGENT; EOTAXIN; KP 496; LEUKOTRIENE RECEPTOR; PREDNISOLONE; RANTES; SEPHADEX; THROMBOXANE A2 RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL COUNT; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; EOSINOPHIL; INFLAMMATION; INFLAMMATORY CELL; LUNG LAVAGE; LYMPHOCYTE ACTIVATION; LYMPHOCYTIC INFILTRATION; MALE; NONHUMAN; RAT; RECEPTOR BLOCKING; RESPIRATORY TRACT DISEASE;

ADMINISTRATION, ORAL; ADULT; ANTI-BACTERIAL AGENTS; BIOLOGICAL AVAILABILITY; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CIPROFLOXACIN; CROSS-OVER STUDIES; DRUG ADMINISTRATION SCHEDULE; DRUGS, CHINESE HERBAL; HUMANS; MALE; MEDICINE, KAMPO; TETRACYCLINE; TIME FACTORS; YOUNG ADULT;

EID: 66549117014     PISSN: 09186158     EISSN: 13475215     Source Type: Journal    
DOI: 10.1248/bpb.32.1080     Document Type: Article

References (31)

1. Breidenbach T., Hoffmann M., Becker T., Schlitt H., Klempnauer J., Lancet, 355, 1912 (2000).
2. Mizuno M., Iinuma M., Yasuda K., Kawada I., Annu. Proc. Gifu Pharm. Univ., 37, 18-28 (1988).
3. Tani T., Medicine Drug J. (Tokyo), 25, 1987-1993 (1989).
4. Liu J. X., "Prospects and Guideline of Combined Usage of Western and Oriental Medicines, Proceedings of the 6th International Congress on Oriental Medicine, October," Japan Association of Oriental Medicine, Tokyo, 1990, pp. 76-80.
5. Chan T. Y., Ann. Pharmacol., 35, 501-504 (2001).
6. Hasegawa T., Yamaki K., Muraoka I., Nadai M., Takagi K., Nabeshima T., Antimicrob. Agents Chemother., 39, 2135-2137 (1995).
7. Khalil S. A., Daabis N. A., Naggar V. F., Wafik M., Pharmazie, 32, 519-522 (1977).
8. Garty M., Hurwitz A., Clin. Pharmacol. Ther., 28, 203-207 (1980).
9. Hoffken G., Borner K., Glatzel P. D., Koeppe P., Lode H., Eur. J. Clin. Microbiol., 4, 345 (1985).
10. Leyden J. J., J. Am. Acad. Dermatol., 12, 308-312 (1985).
11. Neuvonen P. J., Kivistö T., Lehto P., Clin. Pharmacol. Ther., 50, 498-502 (1991).
12. Frost R. W., Lasseter K. C., Noe A. J., Shamblen E. C., Lettieri J. T., Antimicrob. Agents Chemother., 36, 830-832 (1992).
13. Cook H. J., Mundo C. R., Fonseca L., Gasque L., Moreno-Esparza R., Biopharm. Drug Dispos., 14, 549-553 (1993).
14. Sahai J., Healy D. P., Stotka J., Polk R., Br. J. Clin. Pharmacol., 35, 302-304 (1993).
15. Jung H., Peregrina A. A., Rodriguez J. M., Moreno-Esparza R., Biopharm. Drug Dispos., 18, 459-463 (1997).
16. Fish D. N., Pharmacotherapy, 21, 253-272 (2001).
17. Naruhashi K., Tamai I., Inoue N., Muraoka H., Sai Y., Suzuki N., Tsuji A., Antimicrob. Agents Chemother., 46, 344-349 (2002).
18. Agwuh K. N., MacGowan A., J. Antimicrob. Chemother., 58, 256-265 (2006).
19. Kakemi K., Sezaki, H., Ogata H., Nadai T., Chem. Pharm. Bull., 16, 2200-2205. (1968).
20. Sande M. A., Mandell G. L., "Pharmacological Basis of Therapeutics," 7th ed., ed. by Gilman A. G., Goodman L. S., Rall T. W., Murad F., MacMillan Publishing Co., New York, 1985, pp. 1170-1198.
21. Neuvonen P. J., Drugs, 11, 45-54 (1976).
22. Lomaestro B. M., Bailie G. R., Antimicrob. Agents Chemother., 35, 1004-1007 (1991).
23. Lomaestro B. M., Bailie G. R., Ann. Pharmacol., 27, 1325-1328 (1993).
24. Sakai M., Hara A., Anjo S., Nakamura M., J. Pharm. Biomed. Anal., 18, 1037-1067 (1999).
25. Kawai Y., Matsubayashi K., Hakusui H., Chem. Pharm. Bull., 44, 1425-1430 (1996).
26. Aminimanizani A., Beringer P., Jelliffe R., Clin. Pharmacokinet., 40, 169-187 (2001).
27. Babu E., Takeda M., Narikawa S., Kobayashi Y., Yamamoto T., Cha S. H., Sekine T., Sakthisekaran D., Endou H., Jpn. J. Pharmacol., 88, 69-76 (2002).
28. Nishimura N., Yakugaku Zasshi, 125, 363-369 (2005).
29. Zhao Y. L., Cai S. H., Wang L., Kitaichi K., Tatsumi T., Nadai M., Yoshizumi H., Takagi K., Takagi K., Hasegawa T., Clin. Exp. Pharmacol. Physiol., 29, 167-172 (2002).
30. Shimizu A., Miyoshi M., Sugie M., Ueyama J., Yamaguchi T., Sasaki T., Takagi M., Jin M., Miyamoto K., Tsuji A., Hasegawa T., Eur. J. Pharmacol., 501, 151-159 (2004).
31. Ando T., Kusuhara H., Merino G., Alvarez A. I., Schinkel A. H., Sugiyama Y., Drug Metab. Dispos., 35, 1873-1879 (2007).